Price T Rowe Associates Inc Kura Oncology, Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$148 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$145 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$121 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$113 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$94.8 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.4B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...